Inventor · disambiguated record
Ulrich Schraermeyer
Also filed as: SCHRAERMEYER ULRICH
4 granted patents·9 pending applications·31 citations·filing 2002–2023
71Inventor score
Top patents by PatentIndex Score
13 records- 0181US7247479B2Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS diseaseKOCHANEK STEFAN·Filed 2002·Granted Jul 24, 2007·25 cites·7 claims
- 0271US9314453B2Tetrahydropyridoethers for treatment of AMDKATAIRO GMBH·Filed 2013·Granted Apr 19, 2016·1 cites·17 claims
- 0371US2022370425A1Tetrahydropyridoethers for treatment of amdKATAIRO GMBH·Filed 2022·Application pending·0 cites
- 0470US7488749B2Therapy of diseases of the eye, the inner ear and the central nervous systemCEVEC PHARMACEUTICALS GMBH·Filed 2003·Granted Feb 10, 2009·5 cites·1 claims
- 0568US2011046377A1Tetrahydropyridoethers for treatment of amdSCHRAERMEYER ULRICH·Filed 2009·Application pending·0 cites
- 0654US2025144075A1Melanin for treating lipofuscin-associated diseasesKATAIRO GMBH·Filed 2023·Application pending·0 cites
- 0752US2023285399A1Compound for the treatment and prophylaxis of a lipofuscin-associated disease and/or a disease associated with aged oxidized melaninUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2021·Application pending·0 cites
- 0851US2007264244A1Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS diseaseKOCHANEK STEFAN·Filed 2007·Application pending·0 cites
- 0950US2023338483A1Method for the treatment of a disease using pigment epithelium-derived factor (pedf)CUREBIOTECH GMBH·Filed 2021·Application pending·0 cites
- 1046US2016235724A1Tetrahydropyridoethers for the treatment of stargardt's diseaseKATAIRO GMBH·Filed 2014·Application pending·0 cites
- 1145US2016279111A1Tetrahydropyridoethers for the treatment of amdKATAIRO GMBH·Filed 2016·Application pending·0 cites
- 1244US2022133866A1Method for the Treatment of a Disease Using Pigment Epithelium-Derived Factor (PEDF)CUREBIOTEC GMBH·Filed 2020·Application pending·0 cites
- 1343US10495630B2Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositionsKATAIRO GMBH·Filed 2015·Granted Dec 3, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Ulrich Schraermeyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →